Is CAVVF or JNJ a better dividend investment in 2026?

CAVVF currently yields 2055.50% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: CAVVF offers higher current income.

What is the dividend yield difference between CAVVF and JNJ?

CAVVF has a forward dividend yield of 2055.50% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 2053.37 percentage points.

Home › Compare › CAVVF vs JNJ

CAVVF vs JNJ: Dividend Comparison 2026

CAVVF yields 2055.50% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CAVVF wins by $12828287194.98M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CAVVF

● Live price

2055.50%

Share price

$0.10

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$12828287195.01M

Annual income

$11,707,825,857,181,476.00

Full CAVVF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — CAVVF vs JNJ

📍 CAVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CAVVF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CAVVF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CAVVF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAVVF

Annual income on $10K today (after 15% tax)

$174,717.37/yr

After 10yr DRIP, annual income (after tax)

$9,951,651,978,604,254.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, CAVVF beats the other by $9,951,651,978,600,268.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAVVF + JNJ for your $10,000?

CAVVF: 50%JNJ: 50%

100% JNJ50/50100% CAVVF

Portfolio after 10yr

$6414143597.52M

Annual income

$5,853,912,928,593,083.00/yr

Blended yield

91.27%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CAVVF

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAVVF buys

JNJ buys

No recent congressional trades found for CAVVF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCAVVFJNJ

Forward yield	2055.50% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$12828287195.01M ✓	$30.3K
Annual income after 10y	$11,707,825,857,181,476.00 ✓	$4,689.40
Total dividends collected	$12748926998.50M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CAVVF vs JNJ ($10,000, DRIP)

Year	CAVVF Portfolio	CAVVF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$216,250	$205,549.85	$10,592	$272.30	+$205.7K → CAVVF
2	$4,385,604	$4,154,217.05	$11,289	$357.73	+$4.37M → CAVVF
3	$83,429,631	$78,737,034.33	$12,123	$472.89	+$83.42M → CAVVF
4	$1,489,134,673	$1,399,864,967.60	$13,141	$629.86	+$1489.12M → CAVVF
5	$24,944,940,636	$23,351,566,535.79	$14,408	$846.81	+$24944.93M → CAVVF
6	$392,269,666,568	$365,578,580,087.90	$16,021	$1,151.60	+$392269.65M → CAVVF
7	$5,792,510,495,062	$5,372,781,951,834.12	$18,122	$1,588.22	+$5792510.48M → CAVVF
8	$80,345,661,782,925	$74,147,675,553,208.94	$20,930	$2,228.20	+$80345661.76M → CAVVF
9	$1,047,160,128,816,172	$961,190,270,708,442.20	$24,792	$3,191.91	+$1047160128.79M → CAVVF
10	$12,828,287,195,014,780	$11,707,825,857,181,476.00	$30,274	$4,689.40	+$12828287194.98M → CAVVF

CAVVF vs JNJ: Complete Analysis 2026

CAVVF — Stock

CAVU Energy Metals Corp., a mining company, engages in the acquisition, exploration, and development of mineral projects containing metals used in green technologies and the renewable energy sector. The company focuses on the exploration of its Hopper Copper-Gold Porphyry Project in Yukon and Star Copper-Gold Porphyry Project in British Columbia. The company was formerly known as CAVU Mining Corp. and changed its name to CAVU Energy Metals Corp. in May 2022. CAVU Energy Metals Corp. is headquartered in Vancouver, Canada.

Full CAVVF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CAVVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAVVF vs SCHD CAVVF vs JEPI CAVVF vs O CAVVF vs KO CAVVF vs MAIN CAVVF vs ABBV CAVVF vs MRK CAVVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.